Biomarker characterization in Endometrial Cancer in Europe
Endometrial Carcinoma (EC) is the most common gynaecological cancer affecting women in Western populations. This report surveys data analysis from 69 pathology academic and hospital labs to analyse the testing behaviours in endometrial cancer.
Register to become a DXRX member
About the report
This report surveys data analysis from 69 pathology academic and hospital labs. This data was collected regarding daily practice in Endometrial Carcinoma evaluation, specifically concerning mismatch repair status (MMR) and microsatellite instability (MSI).
Using Diaceutic’s DXRX: Diagnostic Network, a global multisource database including commercial claims and laboratory data, the researchers analyzed the endometrial cancer testing behavior in a cohort of European labs who are part of the DXRX Network.
Report Highlights
Explore the daily-based approach to Endometrial Carcinoma diagnostic and management pathways.
The advantages of IHC-based analysis.
POLE testing in endometrial carcinoma.
National/international guidelines followed in endometrial cancer
Biomarkers characterization in Endometrial Cancer in Europe Dashboard
Register and gain access to our Data Dashboards, along with access to LabTalks, Articles, Podcasts & more!
To learn more about the DXRX community and receive marketing communications from us, please sign up via the form below.
